Registration and abstract submissions are now open.
21st International Conference on Emerging Frontiers in Cancer Research
Menu

Cancer Conference of India

21st International Conference on Emerging Frontiers in Cancer Research

Molecular Mechanisms to Personalized Treatments

Being organised by Gautam Buddha University, Greater NOIDA, India in association with Shiv Nadar Institute of Eminence, Greater NOIDA, India, Roswell Park Comprehensive Cancer Centre, Buffalo, USA; Rutgers Health New Jersey Medical School, USA and Cancer Research and Care Academy, New Delhi, India

Dates 29-31 October 2026
Venue Gautam Buddha University and Shiv Nadar Institute of Eminence, Deemed to be University, Greater Noida
Patron Message
Prof. Rana P. Singh photo

Message from the Patron

Prof. Rana P. Singh

Vice Chancellor, Gautam Buddha University, Greater NOIDA, India

Professor of Cancer Biology, School of Life Sciences, Jawaharlal Nehru University, New Delhi

Patron

We are pleased to invite students, early-career scientists, clinicians, researchers, academicians and industry leaders to participate in the 21st International Conference on “Emerging Frontiers in Cancer Research: Molecular Mechanisms to Personalized Treatments”, scheduled from 29–31 October 2026 in Greater NOIDA, India.

Register Now

Collaborators

Collaborating Institutions

The conference is supported by leading academic, research, and healthcare institutions contributing to cancer research, education, and translational science.

Organisers

Convenors and Co-Convenors

Organised under the patronage of Prof. Rana P. Singh, Vice Chancellor, Gautam Buddha University, in collaboration with Shiv Nadar University, Roswell Park Comprehensive Cancer Center, Rutgers Health New Jersey Medical School, and the Cancer Research and Care Academy (CRCA), New Delhi.

International Convenors

Prof. Dhyan Chandra photo
United States flag

International Convenor

Prof. Dhyan Chandra

Professor of Oncology

Roswell Park Comprehensive Cancer Center, Buffalo, USA

Prof. Raymond Birge photo
United States flag

International Convenor

Prof. Raymond Birge

Professor and Vice Chair

Rutgers Health New Jersey Medical School, New Jersey, USA

Convenors

Prof. S. Dhanalakshmi photo
India flag

Convenor

Prof. S. Dhanalakshmi

Dean, University School of Biotechnology

Gautam Buddha University, Greater NOIDA, India

Prof. Sanjeev Gelande photo
India flag

Convenor

Prof. Sanjeev Gelande

Dean, SNS

Shiv Nadar Institute of Eminence, Deemed to be University, Greater NOIDA, India

Co-Convenors

Dr. Rekha Puria photo
India flag

Co-Convenor

Dr. Rekha Puria

HoD, University School of Biotechnology

Gautam Buddha University, Greater NOIDA, India

Dr. Ashish Gupta photo
India flag

Co-Convenor

Dr. Ashish Gupta

Associate Professor, Department of Life Sciences

Shiv Nadar Institute of Eminence, Deemed to be University, Greater NOIDA, India

Important Dates

Deadline reminders and countdowns are CMS-managed.

Key deadlines and milestones.

Ask a Question

01 Jun 2026

Registration Opens

Public registration opens.

15 Sep 2026

Extended Early Bird Deadline

Extended Deadline for early bird registration.

30 Sep 2026

Regular Registration Deadline

Regular Registration Date

15 Sep 2026

Abstract Submission Deadline

Last date for abstract final submission.

15 Sep 2026

Award Application Deadline

Last date for award consideration.

15 Oct 2026

Accommodation Booking Deadline

Accommodation request deadline.

29 Oct 2026

Conference Start Date

Conference begins.

31 Oct 2026

Conference End Date

Conference ends.

Keynote Speakers

Keynote Speakers

View all keynote speakers
Prof G.K. Rath
India flag
Keynote Speaker

Prof G.K. Rath

Ex- Head, Chief Radiologist & Professor

National Cancer Institute (India),

Country of work: India

Cancer Biology and Radiation Oncology

Keynote Lecture

Prof. Justin Lathia
United States flag
Keynote Speaker

Prof. Justin Lathia

Director of Faculty Development

Cleveland Clinic Research,

Country of work: United States

Glioblastoma: Cell adhesion mechanisms, cell-cell communication, and the interaction between tumor cells and the immune system

Keynote Lecture

Dr. Konstantin Salnikow
United States flag
Keynote Speaker

Dr. Konstantin Salnikow

Program Director

National Institutes of Health, USA

Country of work: United States

Role of Iron in Cancer

Keynote Lecture

Dr. Santosh Kesari
United States flag
Keynote Speaker

Dr. Santosh Kesari

Investigator, Cancer Biology and Immunotherapeutics, Founder, Asthra Health

The Lundquist Institute

Country of work: United States

Accelerating precision cancer therapies for rare cancers with AI enabled cureseek platform

Keynote Lecture

Invited Speakers

Invited Speakers

View all invited speakers
Prof. Reshma Taneja
Singapore flag
Invited Speaker

Prof. Reshma Taneja

Head of Department

National University of Singapore

Country of work: Singapore

Prof. Seema Singh
United States flag
Invited Speaker

Prof. Seema Singh

Professor of Cell and Molecular Biology

University of Mississippi Medical Center, U.S

Country of work: United States

Dr. Dhanendra Tomar
United States flag
Invited Speaker

Dr. Dhanendra Tomar

Assistant Professor

Wake Forest University School of Medicine

Country of work: United States

Dr. Pooja Jadiya
United States flag
Invited Speaker

Dr. Pooja Jadiya

Assistant Professor

Wake Forest University School of Medicine

Country of work: United States

Prof. Jerry Edward Chipuk
United States flag
Invited Speaker

Prof. Jerry Edward Chipuk

Professor and Chair

Florida International University

Country of work: United States

Prof. Pankaj K. Singh
United States flag
Invited Speaker

Prof. Pankaj K. Singh

Professor and Founding Chairman

University of Oklahoma Health Sciences Center

Country of work: United States

Prof. Sujit Basu
United States flag
Invited Speaker

Prof. Sujit Basu

Professor of Medical Oncology (Internal Medicine) and Professor of Pathology & Director of Translational Research

The Ohio State University

Country of work: United States

Prof. Gokul Das
United States flag
Invited Speaker

Prof. Gokul Das

Professor

Roswell Park Comprehensive Cancer Center

Country of work: United States

Themes

Conference Themes

Twelve scientific themes span basic, translational, clinical, computational and integrative oncology. Abstracts are invited under any of the themes below.

Emerging trends and new therapeutic targets in cancer

Exploring new molecular targets, emerging biomarkers, and innovative therapeutic strategies shaping the future of cancer treatment.

Small molecules in cancer prevention and therapeutics

Focusing on natural, synthetic, and semi-synthetic small molecules for cancer prevention, control, and treatment.

Cell death modalities in cancer development and treatment

Understanding regulated cell death pathways and their role in cancer progression, therapy response, and resistance.

Basic and translational cancer research

Connecting fundamental cancer biology with translational discoveries for improved diagnosis, prevention, and treatment.

Cancer stemness and resistance to therapy

Investigating cancer stem cells, tumor plasticity, recurrence, metastasis, and mechanisms of therapeutic resistance.

Novel approaches for radiation therapies

Advancing radiation biology, precision radiotherapy, radiosensitization, and combination treatment strategies.

Targeting mitochondria for cancer prevention and treatment

Exploring mitochondrial biology, metabolism, oxidative stress, and mitochondria-targeted strategies in cancer.

Precision oncology and personalized cancer treatment approaches

Using molecular profiling, biomarkers, and patient-specific data to guide individualized cancer treatment.

Ayurveda and integrative medicine in cancer care and inflammatory diseases

Examining evidence-based Ayurvedic and integrative approaches for cancer care, prevention, and inflammatory disease management.

Cancer chemoprevention using natural/herbal and synthetic agents

Studying natural, herbal, dietary, and synthetic agents that prevent or delay cancer development.

Artificial Intelligence and Machine Learning in cancer research

Applying AI, machine learning, and data science to cancer diagnosis, discovery, prediction, and treatment planning.

Systems medicine and cancer

Understanding cancer as a complex biological system through multi-omics, network biology, and integrated data analysis.

Registration CTA

Registration & Fees Preview

Five delegate categories are open across four fee windows. Early bird rates apply until 15 September 2026, from ₹3,000 for undergraduate students and USD 150 for international delegates.

Undergraduate Student Early: INR 3,000.00 Regular: INR 3,500.00
PhD Scholar Early: INR 4,000.00 Regular: INR 4,500.00
Faculty / Scientist Early: INR 5,500.00 Regular: INR 6,500.00
Review Registration Details

Abstract CTA

Submit Abstract

Abstract submission will be payment-gated in a later phase. Public guidelines are available now for delegates and committee review.

Scientific Program

Scientific Program Highlight

Keynote lectures
Plenary sessions
Invited talks
Award sessions
Poster sessions
View Scientific Program

Prof. A. R. Rao Memorial Award

Awards

Prof. A. R. Rao Young Researcher Award

The Prof. A. R. Rao Young Researcher Award is intended to encourage emerging researchers and scholars conducting high-quality research in cancer and allied fields. The award recognizes innovative research, scientific merit, clarity of presentation, and the potential contribution of the work to cancer research and healthcare.

Deadline: 15 Sep 2026

Prof. A. R. Rao Young Scientist Award

The Prof. A. R. Rao Young Scientist Award recognizes promising early-career scientists and young faculty members for outstanding research in cancer prevention, cancer biology, therapeutics, and related areas. The award honors scientific excellence, originality, and the potential impact of the research presented at the conference.

Deadline: 15 Sep 2026

View Awards
Accommodation

Stay & Travel Support

Accommodation Information

Accommodation is available to delegates at the Gautam Buddha University guest house on a paid basis, with prior booking. Both single-occupancy and twin-sharing rooms are offered. Bookings close on 15 October 2026 and are subject to availability.

Accommodation Details

Plan your stay for the conference

In-Campus guest house
Nearby hotel and guest-house options
Room categories and charges
Contact person and booking instructions

Sponsors

Institutional Support & Sponsors

We acknowledge the institutional support agencies, sponsors, and partners contributing to the Cancer Conference of India.

Institutional Sponsors / Institutional Support

Supporting Agencies

Gautam Buddha University, Greater Noida logo

Gautam Buddha University, Greater Noida

Established by the Uttar Pradesh Act (9) of 2002, commenced its first academic session at its 511 acres lush green campus at Greater Noida in August 2008. The University is fully funded by the New Okhla Industrial Development Authority (NOIDA) and the Greater Noida Industrial Development Authority (GNIDA), the undertakings of the Government of Uttar Pradesh. The University is recognized by the University Grants Commission under UGC Act and is a member of the Association of Indian Universities. The academic programmes offered by the University are recognised by the University Grants Commission of India and various other Statutory Bodies, Councils, whichever are applicable in individual cases. Recognition by the University Grants Commission of India (UGC): Gautam Buddha University is recognized by the University Grants Commission of India vide F.9-18/2009 (CRP-I) dated 13 May 2009 under section 2(f) of UGC Act 1956. Through this the University has been empowered to award degrees as specified by UGC under section 22 of the UGC Act 1956 at its main campus with the approval of Statutory Councils, wherever required. Recognition and Inclusion by the University Grants Commission of India (UGC) under section 12 B of the University Grants Commission, UGC ACT 1956. Recognised under UGC Section 12B and NAAC accredited with B+ Grade. Association of Indian Universities Membership: The University has been granted membership of the Association of Indian Universities. Approval by the Bar Council of India: The School of Law, Justice, & Governance administers a five years Integrated B.A. LLB programme. This Programme has been approved by the Bar Council of India. Approval by National Council for Teacher Education (NCTE): The Department of Education & Training, School of Humanities & Social Sciences offer Two-Year B.Ed. Programme recognized by the National Council for Teacher Education (NCTE). Approval by Rehabilitation Council of India: The Department of Psychology & Mental Health, School of Humanities & Social Sciences offers M. Phil. (Clinical Psychology), 2 years Programme which is recognized by the Rehabilitation Council of India. Approval by the Council of Architecture, India: The Department of Architect & Planning, School of Engineering offers B.Arch. and M. Arch. Programmes in Architect and Planning. This programme is recognized by the Council of Architecture, India. ISO 9001: 2008 Certification of the University: Gautam Buddha University has been accredited jointly be Joint Accreditation System of Australia & New Zealand (JAS-ANZ), vide 1015QBC26 after accessing and finding confirmation to the requirements of ISO 9001: 2008.

Shiv Nadar Institution of Eminence, Deemed to be University, Delhi NCR logo

Shiv Nadar Institution of Eminence, Deemed to be University, Delhi NCR

The Shiv Nadar Institution of Eminence is a multidisciplinary, student-centric research university established in 2011 by Shiv Nadar, one of India’s foremost philanthropists and a pioneer of technological revolution. It has four Schools, viz., Engineering, Natural Sciences, Humanities and Social Sciences, Management & Entrepreneurship, and the Academy of Continuing Education. We were the first university in the country to offer a 4-year multidisciplinary research degree. Today, we are continuing as trailblazers with new kinds of curriculum, championed by faculty drawn from some of the top institutions in the country and the world. With low faculty-student ratios, their in-depth attention to students lead to high levels of student success.

Department of Biotechnology, Government of India logo

Department of Biotechnology, Government of India

The journey of the Department of Biotechnology started as the National Biotechnology Board (NBTB) in 1982, evolving soon after in 1986 into a full-fledged Department under the Ministry of Science & Technology. The Department aims to be at the forefront of the Biotech Revolution, which possesses a potential for socioeconomic transformation far exceeding even the Information Technology Revolution of the past decades.

Department of Science & Technology, Government of India logo

Department of Science & Technology, Government of India

Established in May 1971, with the objective of promoting new areas of Science & Technology and to play the role of a nodal department for organising, coordinating and promoting S&T activities in the country. The Department has major responsibilities for specific projects and programmes as listed below: Formulation of policies relating to Science and Technology. Matters relating to the Scientific Advisory Committee of the Cabinet (SACC). Promotion of new areas of Science and Technology with special emphasis on emerging areas. Research and Development through its research institutions or laboratories for development of indigenous technologies concerning bio-fuel production, processing, standardization and applications, in co-ordination with the concerned Ministry or Department; Research and Development activities to promote utilization of by-products to development value added chemicals. Futurology. Coordination and integration of areas of Science & Technology having cross-sectoral linkages in which a number of institutions and departments have interest and capabilities. Undertaking or financially sponsoring scientific and technological surveys, research design and development, where necessary. Support and Grants-in-aid to Scientific Research Institutions, Scientific Associations and Bodies. All matters concerning: Science and Engineering Research Council; Technology Development Board and related Acts such as the Research and Development Cess Act,1986 (32 of 1986) and the Technology Development Board Act,1995 (44 of 1995); National Council for Science and Technology Communication; National Science and Technology Entrepreneurship Development Board; International Science and Technology Cooperation including appointment of scientific attaches abroad (These functions shall be exercised in close cooperation with the Ministry of External Affairs); Autonomous Science and Technology Institutions relating to the subject under the Department of Science and Technology including Institute of Astro-physics, and Institute of Geo-magnetism; Professional Science Academies promoted and funded by Department of Science and Technology; The Survey of India, and National Atlas and Thematic Mapping Organisation; National Spatial Data Infrastructure and promotion of G.I.S; The National Innovation Foundation, Ahmedabad. Matters commonly affecting Scientific and technological departments/organisations/ institutions e.g. financial, personnel, purchase and import policies and practices. Management Information Systems for Science and Technology and coordination thereof. Matters regarding Inter-Agency/Inter-Departmental coordination for evolving science and technology missions. Matters concerning domestic technology particularly the promotion of ventures involving the commercialization of such technology other than those under the Department of Scientific and Industrial Research. All other measures needed for the promotion of science and technology and their application to the development and security of the nation. Matters relating to institutional Science and Technology capacity building including setting up of new institutions and institutional infrastructure. Promotion of Science and Technology at the State, District, and Village levels for grass- roots development through State Science and Technology Councils and other mechanisms. Application of Science and Technology for weaker sections, women and other disadvantaged sections of Society.

Council of Science and Technology, U.P. logo

Council of Science and Technology, U.P.

The Government of Uttar Pradesh in October, 1972 constituted a Working group on the Role and Development of Science and Technology in relation to the Fifth Five Year Plan of the State. This Working Group was charged with the task of examining inputs and infrastructure available and required for growth of Science and Technology and its application to the process of development, for identifying problems and programs for research and development, and for preparing an integrated plan for action for development and application of Science and Technology in the State during the Fifth Plan period. The Concept of Research and Development as projected in the "Approach to the Science and Technology Plan" prepared by the National Committee on Science and Technology was found to be very wide ranging. To cover it, one of the main recommendations of the Working group was the need for establishing a State Council of Science and Technology with a Department of Science and Technology for Administrative support, which was bound to take up the recommendations of this Working Group to push forward all the schemes and activities which were included in the Fifth Plan. This recommendation of the Working Group provided the case for establishing the "Council of Science and Technology, U.P." and it was established on 1st May' 1975 by the Government of Uttar Pradesh with the Department of Science and Environment for administrative support. The Council of Science and Technology, U.P. (CST, U.P.) was given an autonomous status as a registered body under Societies Registration Act, 1860.

Patanjali Research Foundation logo

Patanjali Research Foundation

Established in 2017, Patanjali Research Foundation, governed by Patanjali Research Foundation (Trust), is a fully integrated innovative Research Foundation to conduct modern experimentation on Ayurvedic medicines for the treatment of various diseases. The institute has a diversified research portfolio and a substantial clinical testing pipeline. Our main focus is mainly in herbal Research and Development arena.

Other Sponsors

Conference Sponsors

Sponsors will be announced soon.
Need help?

Frequently Asked Questions

Find quick answers about the conference, registration, abstracts, awards, accommodation and support.

When and where is the 21st International Conference on Emerging Frontiers in Cancer Research being held?

The conference is held from 29 to 31 October 2026. Days 1 and 2 (29-30 October) take place at Gautam Buddha University, Yamuna Expressway, Greater Noida, Uttar Pradesh 201312, India. Day 3 (31 October) takes place at Shiv Nadar Institute of Eminence, Deemed to be University, Greater Noida, Uttar Pradesh 201314, India. It is an in-person conference.

What is the theme of the conference?

The theme is 'Molecular Mechanisms to Personalized Treatments'. The conference covers 12 themed tracks including emerging therapeutic targets, small molecules in cancer prevention, cell death modalities, basic and translational cancer research, cancer stemness and therapy resistance, novel radiation therapy approaches, targeting mitochondria, precision oncology, Ayurveda and integrative medicine, chemoprevention using natural and synthetic agents, artificial intelligence and machine learning in cancer research, and systems medicine.

Who is organising the conference?

It is organised by Gautam Buddha University, Greater Noida, in collaboration with Shiv Nadar Institute of Eminence (Greater Noida), Roswell Park Comprehensive Cancer Center (Buffalo, USA), Rutgers Health New Jersey Medical School (USA) and the Cancer Research and Care Academy (New Delhi). The Patron is Prof. Rana P. Singh, Vice Chancellor of Gautam Buddha University. International Convenors are Prof. Dhyan Chandra (Roswell Park) and Prof. Raymond Birge (Rutgers Health New Jersey Medical School). Convenors are Prof. S. Dhanalakshmi (Gautam Buddha University) and Prof. Sanjeev Gelande (Shiv Nadar Institute of Eminence). The conference is organised and managed by Labify, Samviti Private Limited.

What are the registration fees?

Early bird fees (25 March to 15 September 2026) are INR 3,000 for undergraduate students, INR 4,000 for PhD scholars, INR 5,500 for faculty and scientists, INR 10,000 for industry delegates and USD 150 for international delegates. Regular fees (16-30 September 2026) are INR 3,500, INR 4,500, INR 6,500, INR 12,000 and USD 200 respectively. Late fees (1-15 October 2026) are INR 4,000, INR 5,500, INR 7,500, INR 15,000 and USD 250. Spot fees (16-31 October 2026) are INR 5,000, INR 6,500, INR 8,000, INR 18,000 and USD 300, subject to availability. Student categories require valid institutional proof.

What are the important dates and deadlines?

Registration opened on 1 June 2026. The extended early bird registration deadline, the abstract submission deadline and the award application deadline are all 15 September 2026. The regular registration deadline is 30 September 2026. The accommodation booking deadline is 15 October 2026. The conference runs 29-31 October 2026.

How do I register and submit an abstract?

Registration is at cancerconferenceindia.com/registration. All delegates must first create an account and complete their profile so that registration category and eligibility can be verified. Abstract submission is payment-gated: the receipt, invitation letter and abstract submission access are enabled only after verified successful payment or approved manual payment. Abstracts are then submitted at cancerconferenceindia.com/abstract-submission following the published guidelines, reviewed by reviewers, and accepted abstracts are mapped to oral or poster presentation.

Who should attend this cancer research conference?

The conference is designed for cancer biologists, molecular biologists, clinicians, translational researchers, biotechnology professionals, PhD scholars, postdoctoral fellows, students, public health researchers, computational scientists, industry professionals and young scientists interested in emerging areas of oncology.

Who are the keynote speakers?

Keynote speakers are Prof. G. K. Rath (National Cancer Institute, India) on cancer biology and radiation oncology; Prof. Justin Lathia (Cleveland Clinic Research, USA) on glioblastoma cell adhesion mechanisms, cell-cell communication and tumour-immune interaction; Dr. Konstantin Salnikow (National Institutes of Health, USA) on the role of iron in cancer; and Santosh Kesari (The Lundquist Institute, USA) on cancer biology and immunotherapeutics. Over 35 further invited speakers from India, the United States, Singapore, the United Kingdom, Canada and Australia are listed at cancerconferenceindia.com/speakers.

Are there awards for young researchers?

Yes. The Prof. A. R. Rao Young Researcher Award encourages emerging researchers and scholars conducting high-quality research in cancer and allied fields. The Prof. A. R. Rao Young Scientist Award recognises promising early-career scientists and young faculty members for outstanding research in cancer prevention, cancer biology, therapeutics and related areas. The application deadline for both is 15 September 2026.

Is accommodation available for delegates?

Yes. On-campus guest house accommodation at Gautam Buddha University is available with shared and individual room options, and additional nearby hotel and guest-house options are listed. The accommodation booking deadline is 15 October 2026. Details are at cancerconferenceindia.com/accommodation.

How can I contact the conference secretariat?

Email crcadelhi@gmail.com or call +91 80762 33525. WhatsApp support is available at the same number. Support hours are Monday to Friday, 10:00 AM to 5:00 PM IST. The secretariat address is Conference Secretariat, Gautam Buddha University, Greater Noida, Uttar Pradesh, India.

Is this the first edition of the conference?

No. This is the 21st edition; the series has previously completed 20 conferences. This edition continues a long-standing academic effort in cancer research in India.

Contact / WhatsApp CTA

Contact and WhatsApp Support

Contact the secretariat for registration, abstract, awards, scientific program, sponsorship or accommodation queries.

Registration & Fees WhatsApp